Related Experiment Video
Updated: Feb 8, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma
Kristof Harda1, Zsuzsanna Szabo2, Erzsebet Szabo3
1Department of Biopharmacy, University of Debrecen, 4032 Debrecen, Hungary. harda.kristof@pharm.unideb.hu.
Abstract:
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, with an incidence of 4⁻5 cases per million. The prognosis of UM is very poor. In the present study, our aim was to investigate the expression of mRNA and protein for somatostatin receptor types-1, -2, -3, -4, -5 (SSTR-1⁻5) in human UM tissue samples and in OCM-1 and OCM-3 human UM cell lines by qRT-PCR, western blot and ligand competition assay. The mRNA for SSTR-2 showed markedly higher expression in UM tissues than SSTR-5. The presence of SSTRs was demonstrated in 70% of UM specimens using ligand competition assay and both human UM models displayed specific high affinity SSTRs. Among the five SSTRs, the mRNA investigated for SSTR-2 and SSTR-5 receptors was strongly expressed in both human UM cell lines, SSTR-5 showing the highest expression. The presence of the SSTR-2 and SSTR-5 receptor proteins was confirmed in both cell lines by western blot. In summary, the expression of somatostatin receptors in human UM specimens and in OCM-1 and OCM-3 human UM cell lines suggests that they could serve as a potential molecular target for therapy of UM using modern powerful cytotoxic SST analogs targeting SSTR-2 and SSTR-5 receptors.
Insights
Uveal melanoma (UM) is a rare eye cancer. This study found that somatostatin receptors (SSTRs), specifically SSTR-2 and SSTR-5, are expressed in UM tissues and cell lines, suggesting they are potential therapeutic targets.
Area of Science:
- Ophthalmology
- Oncology
- Molecular Biology
Background:
- Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.
- UM has a very poor prognosis, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the expression of somatostatin receptor types 1-5 (SSTR-1⁻5) mRNA and protein in human UM tissues and cell lines.
- To evaluate SSTRs as potential molecular targets for UM therapy.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for mRNA expression.
- Western blot analysis for protein expression.
- Ligand competition assay to confirm receptor presence and affinity.
Main Results:
- SSTR-2 mRNA showed higher expression in UM tissues compared to SSTR-5.
- SSTRs were detected in 70% of UM specimens.
- Both OCM-1 and OCM-3 UM cell lines exhibited high-affinity SSTRs, with SSTR-5 mRNA showing the highest expression and SSTR-2 and SSTR-5 proteins confirmed by western blot.
Conclusions:
- The expression of SSTR-2 and SSTR-5 in UM suggests these receptors are viable molecular targets.
- Targeting SSTR-2 and SSTR-5 with somatostatin (SST) analogs may offer a new therapeutic avenue for UM treatment.
Related Concept Videos
Internal Receptors
Molecular Models
Receptor-mediated Endocytosis
Molecular Orbital Theory II
Molecular Orbital Theory I
Predicting Molecular Geometry

